Evidence map›Paper›PMID 32478879›Full record

Trial reportInternational journal of cosmetic science2020

Pigmentation effects of blue light irradiation on skin and how to protect against them.

R Campiche, S J Curpen, V Lutchmanen-Kolanthan, S Gougeon, M Cherel, G Laurent, M Gempeler, R Schuetz

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in International journal of cosmetic science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Observational
  9. Photooxidative molecular damage under blue light.Experimental & molecular medicine · 2026
    Review
  10. Visible light induces skin darkening in vivo: comparative pilot studies reveal enhanced susceptibility in melasma and its mitigation by a human tyrosinase inhibitor.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Microalgae: revolutionizing skin repair and enhancement.Biotechnology reports (Amsterdam, Netherlands) · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

R CampicheDSM Nutritional Products, Personal Care & Aroma, Wurmisweg 576, Kaiseraugst, 4303, Switzerland.ORCID https://orcid.org/0000-0002-2216-7851
S J CurpenCentre International de Développement Pharmaceutique (CIDP), BioPark Mauritius, SOCOTA Phoenicia, Sayed Hossen Road, Phoenix, 73408, Mauritius.
V Lutchmanen-KolanthanCentre International de Développement Pharmaceutique (CIDP), BioPark Mauritius, SOCOTA Phoenicia, Sayed Hossen Road, Phoenix, 73408, Mauritius.
S GougeonNewtone Technologies, 13 bis Place Jules Ferry, Lyon, 69006, France.
M CherelNewtone Technologies, 13 bis Place Jules Ferry, Lyon, 69006, France.
G LaurentDSM Nutritional Products, Personal Care & Aroma, Wurmisweg 576, Kaiseraugst, 4303, Switzerland.
M GempelerDSM Nutritional Products, Personal Care & Aroma, Wurmisweg 576, Kaiseraugst, 4303, Switzerland.
R SchuetzDSM Nutritional Products, Personal Care & Aroma, Wurmisweg 576, Kaiseraugst, 4303, Switzerland.ORCID https://orcid.org/0000-0003-2410-6128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVisible light, in particular blue light, has been identified as an additional contributor to cutaneous photoageing. However, clinical studies demonstrating the clear effect of blue light on photoageing are still scarce, and so far, most studies have focused on broad-spectrum visible light. Although there is evidence for increased skin pigmentation, the underlying mechanisms of photoageing in vivo are still unclear. Furthermore, there is still a need for active ingredients to significantly protect against blue light-induced hyperpigmentation in vivo. Our study had two aims: to detect visible changes in skin pigmentation following repeated irradiation of the skin with LED-based blue light and to reduce pigmentation using suitable active ingredients.

methodWe conducted a randomized, double-blind and placebo-controlled clinical study on 33 female volunteers with skin phototypes III and IV. We used a repetitive blue light (4 × 60 J cm

resultsWe measured significant changes in chromophore status (P < 0.001 vs baseline), that is of melanin, haemoglobin and oxygen saturation, immediately after blue light irradiation. In addition, we found visible skin colour changes which were expressed by a significant decrease in ITA° values (delta ITA° = -16.89, P < 0.001 vs baseline for the placebo group) and an increase in a* (delta a* = +3.37, P < 0.001 vs baseline for the placebo group) 24 h post-irradiation. Hyperpigmentation and skin reddening were mitigated by both a formulation containing 3% of a microalgal product and a formulation containing 3% niacinamide.

conclusionOur study sets out an efficient and robust protocol for investigating both blue light-induced cutaneous alterations, such as changes in skin chromophores, and signs of photoageing, such as hyperpigmentation. Moreover, we have shown evidence that both an extract of the microalga Scenedesmus rubescens and niacinamide (vitamin B3) have the potential to protect against blue light-induced hyperpigmentation.

Indexed as

LightAdministration, CutaneousAdultDouble-Blind MethodFemaleHumansNiacinamidePlacebosSkin AgingSkin PigmentationYoung AdultNiacinamidePlacebosBlue lighthyperpigmentationniacinamideScenedesmus rubescensskin

Identifiers

PMID32478879
PMCPMC7496068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.